Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmozyme for Chronic Sinusitis in Cystic Fibrosis
NCT01155752Phase 3Withdrawn
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Jul 2013
- Primary completion
- Jun 2014
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dornase alfa in sinusitis, sponsored by Penn State Health Milton S. Hershey Medical Center. Planned start Jul 2013; status: withdrawn.
02
Drugs
dornase alfa
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT01155752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155752.